Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Mucolytics, ICS/LABA combinations cut stroke risk among COPD patients with allied conditions

02 Mar 2022

Patients with chronic obstructive pulmonary disease (COPD) and allied conditions are at heightened risk of stroke, but treatment with mucolytic agents and the combination of inhaled corticosteroids (ICS) plus long-acting β2-agonists (LABA) may protect against the risk, as shown in a study.

02 Mar 2022

Pfizer vax highly effective against severe COVID-19 in teens

01 Mar 2022 bởi

The BNT162b2 mRNA vaccine proves to be highly effective against COVID-19 hospitalization and critical illness in adolescents aged 12 to 18 years, including those with pre-existing comorbidities, according to real-world data from the Overcoming COVID-19 surveillance network sponsored by the US CDC.

01 Mar 2022

First data from Vaccine Allergy Safety clinics reaffirm COVID-19 vaccine safety

01 Mar 2022 bởi

First data from Vaccine Allergy Safety (VAS) clinics in Hong Kong show that a majority of high-risk patients can receive coronavirus disease 2019 (COVID-19) vaccination safely, with no immediate allergic reactions.

01 Mar 2022

Early ivermectin does not prevent progression to severe COVID-19

28 Feb 2022 bởi

The early addition of ivermectin to standard of care (SoC)* in high-risk patients with mild-to-moderate COVID-19 did not prevent progression to severe disease compared with SoC alone, according to results of the I-TECH** trial conducted in Malaysia.

28 Feb 2022

Pneumonia predisposes patients to chronic otitis media

26 Feb 2022

Patients with pneumonia appear to be at increased risk of developing chronic otitis media, a study has found.

26 Feb 2022

Long-term CPAP therapy boosts survival in obstructive sleep apnoea

24 Feb 2022

Among obstructive sleep apnoea patients treated in a real-world setting, those who persist with continuous positive airway pressure (CPAP) therapy may fare better in terms of mortality risk than those who terminate CPAP within the first year of treatment, a study has found.

24 Feb 2022

Booster dose effective in reducing COVID-19 across ages in adults

23 Feb 2022 bởi

The risk of COVID-19 is substantially reduced in adults who receive a third “booster” dose of the BNT162b2 vaccine regardless of their age, according to a study from Israel.

23 Feb 2022

Nonobstructive chronic bronchitis ups risk of death among smokers

19 Feb 2022

Patients with nonobstructive chronic bronchitis are at heightened risk of death, but this association is only present among current and former smokers, according to a systematic review and meta-analysis.

19 Feb 2022

Stroke risk elevated first 3 days post–COVID-19 diagnosis

18 Feb 2022 bởi

Older patients with COVID-19 may have an increased risk of being hospitalized for acute ischaemic stroke (AIS), particularly in the first 3 days following their COVID-19 diagnosis, according to a study presented at ISC 2022.

18 Feb 2022

IM noninferior to IV sotrovimab for COVID-19

17 Feb 2022 bởi

In high-risk nonhospitalized patients with mild-to-moderate COVID-19, intramuscular administration of the monoclonal antibody sotrovimab was noninferior to IV infusion of the drug, according to findings from the phase III COMET-TAIL trial presented at CROI 2022.

17 Feb 2022